Investment
Features
FeesSafety
Academy
More
Pluang+

Compare TG Therapeutics Inc (TGTX) vs Under Armour Inc Class A (UAA) Price & Performance

TG Therapeutics IncTrade
Under Armour Inc Class ATrade

Price performance (Past 24H)

Key statistics

TG Therapeutics Inc vs Under Armour Inc Class A — how do they compare? TG Therapeutics Inc trades at $54.06 (market cap $8.26B), while Under Armour Inc Class A trades at $7.3 (market cap $3.07B). The key difference: TG Therapeutics Inc is far larger — about 2.7× Under Armour Inc Class A's market cap. Which is the better fit depends on your goals.

TGTXUAA
Market Cap
$8.26B$3.07B
Sector
HealthConsumer Cyclical
52-Week High
$59.06$8.14
52-Week Low
$26.39$4.17
Enterprise Value
$8.50B$4.70B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About TG Therapeutics Inc

TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.

Read more on TGTX

About Under Armour Inc Class A

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America and other territories. Consumers of its apparel include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996.

Read more on UAA